RG
Redmile Group’s UnitedHealth UNH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-53,445
| Closed | -$27.3M | – | 73 |
|
2022
Q1 | $27.3M | Sell |
53,445
-51,043
| -49% | -$26M | 0.85% | 34 |
|
2021
Q4 | $52.5M | Sell |
104,488
-16,222
| -13% | -$8.15M | 1.19% | 25 |
|
2021
Q3 | $47.2M | Buy |
120,710
+26,245
| +28% | +$10.3M | 0.82% | 40 |
|
2021
Q2 | $37.8M | Sell |
94,465
-19,911
| -17% | -$7.97M | 0.56% | 48 |
|
2021
Q1 | $42.6M | Sell |
114,376
-110,263
| -49% | -$41M | 0.6% | 52 |
|
2020
Q4 | $78.8M | Buy |
+224,639
| New | +$78.8M | 0.95% | 35 |
|
2020
Q3 | – | Sell |
-103,900
| Closed | -$30.6M | – | 90 |
|
2020
Q2 | $30.6M | Sell |
103,900
-137,200
| -57% | -$40.5M | 0.57% | 46 |
|
2020
Q1 | $60.1M | Buy |
241,100
+38,000
| +19% | +$9.48M | 1.69% | 18 |
|
2019
Q4 | $59.7M | Buy |
203,100
+202,129
| +20,817% | +$59.4M | 1.43% | 24 |
|
2019
Q3 | $211K | Sell |
971
-140,930
| -99% | -$30.6M | 0.01% | 71 |
|
2019
Q2 | $34.6M | Buy |
141,901
+9,011
| +7% | +$2.2M | 0.98% | 29 |
|
2019
Q1 | $32.9M | Buy |
132,890
+17,390
| +15% | +$4.3M | 0.96% | 36 |
|
2018
Q4 | $28.8M | Sell |
115,500
-30,320
| -21% | -$7.55M | 1.16% | 29 |
|
2018
Q3 | $38.8M | Buy |
145,820
+2,800
| +2% | +$745K | 1.19% | 30 |
|
2018
Q2 | $35.1M | Sell |
143,020
-2,400
| -2% | -$589K | 1.19% | 30 |
|
2018
Q1 | $31.1M | Sell |
145,420
-3,200
| -2% | -$685K | 1.2% | 29 |
|
2017
Q4 | $32.8M | Buy |
148,620
+146,800
| +8,066% | +$32.4M | 1.42% | 24 |
|
2017
Q3 | $356K | Hold |
1,820
| – | – | 0.02% | 60 |
|
2017
Q2 | $337K | Hold |
1,820
| – | – | 0.02% | 54 |
|
2017
Q1 | $298K | Hold |
1,820
| – | – | 0.02% | 57 |
|
2016
Q4 | $291K | Hold |
1,820
| – | – | 0.03% | 47 |
|
2016
Q3 | $255K | Buy |
+1,820
| New | +$255K | 0.02% | 45 |
|
2016
Q1 | – | Sell |
-187,034
| Closed | -$22M | – | 54 |
|
2015
Q4 | $22M | Buy |
+187,034
| New | +$22M | 1.65% | 21 |
|
2013
Q3 | – | Sell |
-3,200
| Closed | -$210K | – | 57 |
|
2013
Q2 | $210K | Buy |
+3,200
| New | +$210K | 0.04% | 45 |
|